Articles

  • Jul 18, 2024 | hrdconnect.com | HRD Connect |Tim Smith |Agnes Gatkowska

    We sent a code to your email. Enter the 6-digit verification code sent to

  • Feb 3, 2024 | journalgazette.net | Tim Smith

    Since declaring my candidacy for Indiana’s 3rd Congressional District back in July, I have spoken with thousands of voters throughout northeast Indiana. The No. 1 concern I hear: President Joe Biden’s open border policies threaten our nation’s safety and security. The Secretary of Homeland Security’s job is to keep our nation safe.

  • Dec 17, 2023 | newsbreak.com | Tim Smith

    By signing up for our newsletter, you agree to our Terms of Use and Privacy Policy

  • Dec 17, 2023 | consultantlive.com | Tim Smith

    One of the most hotly anticipated US Food and Drug Administration’s (FDA) approvals in dermatology was that of roflumilast foam, 0.3%, for patients aged 9 years and older with seborrheic dermatitis. This FDA approval marks the first approved drug for seborrheic dermatitis with a new mechanism of action in almost 20 years, and it is a milestone for patients in a large age bracket with the inflammatory skin condition.

  • Dec 11, 2023 | consultantlive.com | Tim Smith

    December 11, 2023It has been a year of ups and downs for dermatologists looking to break ground with different skin diseases. In the ever-expanding field of dermatology, 2023 still emerged as a pivotal year marked by major strides and occasional setbacks. From rare skin diseases such as hidradenitis suppurativa (HS) to more common conditions such as alopecia areata, the treatment space has never had so many options in the armamentarium.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →